Related Experiment Video
Updated: Jun 2, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Factors associated with p53 nuclear accumulation in prostatic adenocarcinoma
Z Zhang1, A Aprikian, A Sarkis
1MEM SLOAN KETTERING CANC CTR,DEPT SURG,UROL SERV,NEW YORK,NY 10021. MEM SLOAN KETTERING CANC CTR,DEPT SURG,COLORECTAL SERV,NEW YORK,NY 10021. MEM SLOAN KETTERING CANC CTR,DEPT PATHOL,NEW YORK,NY 10021.
Abstract:
Prostatic adenocarcinoma is an age-related cancer. The extremely high proportion of this disease with advanced age merits the study of age-dependent carcinogenesis. TP53 is considered a common target for carcinogenic agents including exogenous carcinogens as well as endogenous mutagens. Mutations of this gene are reported to be the most frequent nuclear abnormalities in human cancer. In order to investigate the relationship between age and altered patterns of p53 expression, we have analyzed a group of 48 patients with primary prostatic adenocarcinoma. We assessed p53 nuclear accumulation immunohistochemically by the anti-p53 antibodies PAb1801 and CM-1, and identified 9 out of 48 patients (19%) displaying p53-positive phenotype. We observed a significant association between advanced age and p53 nuclear accumulation. The data suggest that p53 nuclear accumulation may be related to the aging process in prostatic adenocarcinoma.
More Related Videos
04:56Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
09:32Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
Published on: September 10, 2017
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...